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Abstract. We present a unified framework to predict tumor proliferation
scores from breast histopathology whole slide images. Our system offers
a fully automated solution to predicting both a molecular data-based,
and a mitosis counting-based tumor proliferation score. The framework
integrates three modules, each fine-tuned to maximize the overall perfor-
mance: An image processing component for handling whole slide images,
a deep learning based mitosis detection network, and a proliferation
scores prediction module. We have achieved 0.567 quadratic weighted
Cohen’s kappa in mitosis counting-based score prediction and 0.652 F1-
score in mitosis detection. On Spearman’s correlation coefficient, which
evaluates predictive accuracy on the molecular data based score, the
system obtained 0.6171. Our approach won first place in all of the three
tasks in Tumor Proliferation Assessment Challenge 2016 which is MIC-
CAI grand challenge.
Keywords: Tumor proliferation, Mitosis detection, Convolutional neu-
ral networks, Breast histopathology
1 Introduction
Tumor proliferation speed is an important biomarker for estimating the prog-
nosis of breast cancer patients [12]. The mitotic count is part of the Bloom
& Richardson grading system [5], and a well-recognized prognostic factor [2].
However, the procedure currently used by pathologists to count the number
of mitoses is tedious and subjective, and can suffer from reproducibility prob-
lems [13]. Automatic methods have rapidly advanced the state-of-the-art in mito-
sis detection [1,4,14]. In particular, systems based on deep convolutional neural
networks(DCNN) have been successfully adopted to mitosis detection [4]. The
latter family of algorithms have advanced the performance of automatic mitosis
detection to near-human levels, offering promise in addressing the problem of
subjectivity and reproducibility [13].
In a practical scenario, it is desirable to provide tumor proliferation assess-
ment at the whole slide image (WSI) level. The size of the WSI is exceedingly
large, posing additional challenges for applying automatic techniques. Previous
studies carried out mitosis detection within ROI patches from the WSI which
were pre-selected by a pathologist. On the contrary, automatic analysis of the
ar
X
iv
:1
61
2.
07
18
0v
2 
 [c
s.C
V]
  1
1 A
ug
 20
17
2 K. Paeng et al.
Training
Overview
Whole slide image
Tissue region extraction
Patch extraction at x40
ROI detection using cell density
...
Staining 
normalization
Mitosis 
Detection
Network
1. The number of mitosis
2. The number of cells
Feature vector based on 
statistical information
Support Vector 
Classification
Support Vector 
Regression
Mitosis count
based score
Molecular data 
based score
Auxiliary set 
for mitosis detection
mitosis non-mitosis
Fig. 1. Tumor proliferation score prediction framework. First, tissue region and patch
extraction is performed and ROI patches are selected. After staining normalization,
we count the number of mitoses using a DCNN based detection network. The mitosis
detection network is trained by using a dataset containing annotated mitosis regions.
The results of mitosis detection are converted to a feature vector in each WSI. Finally,
the tumor proliferation scores are predicted by SVMs.
WSI must resolve the issue of ROI selection without human guidance. An ad-
ditional module is required to perform the final mapping between a mitosis
counting result and the tumor proliferation score.
In this paper, we present our work in addressing each of the issues outlined
above, in the form of a unified framework for predicting a tumor proliferation
score directly from breast histopathology WSIs. Our pipeline system performs
fully automatic prediction of tumor proliferation scores from WSIs. Our system
participated in a well-recognized challenge and was able to outperform other
systems in each subtask, as well as in the final proliferation score prediction
task, validating the design choices of each module, as well as the capability of
the integrated system.
2 Methodology
2.1 Whole Slide Image Handling
Tissue region and patch extraction: We first identify tissue blobs from
WSI, through a combination of WSI resizing, tissue region extraction by Otsu’s
method, and binary dilation. Once the tissue blobs have been determined, we
sample patches from them to be used in mitosis counting. There are many ways
to perform the patch sampling, in terms of the choice of patch size and sampling
step. Recalling the fact that Bloom & Richardson (B&R) grading depends on
the number of mitoses within a 10 consecutive high power fields (HPFs) region,
an area of approximately 2 mm2, we extract patches corresponding to 10 HPFs.
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Tissue region extraction
TE-100TE-18 TE-140
Fig. 2. The results of tissue region and patch extraction. The blue dots indicate the
position of the sampling point (i.e., the centers of sampled patches). Each green square
shows a 10 consecutive HPFs region.
However, the definition of 10 consecutive HPFs region is highly variant, for
instance, it may have only horizontal or vertical directions. For generality, we
define 10 consecutive HPFs to be a square. The average number of patches
extracted in each slide is roughly 300. The result of tissue region and patch
extraction is shown in Fig. 2.
Region of interests detection: To select region of interests (ROIs) from the
sampled patches, we utilize the fact that there are generally many mitoses in
regions with high cell density. We use CellProfiler [3,7], to estimate the cell
density of the patches. Finally, we obtain the number of cells in each patch, and
after sorting patches from one WSI according to the number of cells, the top K
patches are chosen as ROIs. We set K to 30 with consideration for computation
cost.
Staining normalization: Because WSIs vary highly in appearance, it is ben-
eficial to normalize the staining quality of ROI patches. In order to normalize
the staining of patches, we apply the method described in [9]. We set α and β
to 1.0 and 0.15 respectively.
2.2 Deep Convolutional Neural Networks based Mitosis Detection
Training procedure: After selecting ROI patches, we detect mitoses using the
trained model. The mitosis detector is trained on 128x128 patches extracted
from the auxiliary dataset. We use a two step training procedure in order to
reduce the false positive rate [4]. First, a first-pass training of the network is
performed on an initial dataset. Then, a list of image regions that the network
has identified as false positive mitoses cases is extracted by the trained network.
After that, we build a new, second training dataset which consists of the same
ground truth mitosis samples and normal samples from before, but with an
additional 100,000 normal samples (i.e., false positives) generated with random
translation augmentation from the initially trained network. In total, the new
dataset consists of 70,000 mitosis patches and 280,000 normal patches. We retrain
the network from scratch on this new dataset to obtain the final mitosis detection
model.
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Fig. 3. The L-view network architecture for mitosis detection. k is a depth factor (2 or
3). The dotted line indicates that it is repeated k times. Two red rectangles indicate
corresponding regions in the architecture.
Architecture: The architecture of the mitosis detection network is based on the
Residual Network (ResNet) [6], and it consists of 6 or 9 residual blocks. We train
a network on 128x128 input patches, then convert the trained network to a fully
convolutional network [8], which can then be applied directly to an entire ROI
patch for inference. This method offers much greater computational efficiency
over the alternative of subdividing the ROI patch and performing piecewise in-
ference. However, although the fully convolutional approach is much faster, it
fails to exactly match the performance of the standard subdivision approach.
This problem arises from the large discrepancy between the input size of the
network during training and inference when using the fully convolutional tech-
nique, exacerbated by the ResNet’s large depth leading to a larger receptive field
and corresponding larger zero-padding exposure. In order to alleviate this prob-
lem, we introduce a novel architecture named large-view (L-view) model. Fig. 3
shows the L-view architecture. Although the L-view architecture has 128x128
input size, in the final global pooling layer, we only activate a smaller region
corresponding to the central 64 x 64 region in the input patch. This allows the
zero padding region to be ignored in the training phase and consequently solves
the problem of the zero padding effect, leading to a sizable improvement in mi-
tosis detection score. Fig. 4 represents the examples of mitosis detection results.
Mitosis detection
Fig. 4. Mitosis detection examples. The detected mitoses are highlighted with cyan
circles.
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Table 1. Feature components for predicting tumor proliferation scores. # and mts
represents the number and mitosis, respectively. B&R is Bloom& Richardson grading.
Top 10% and 30-70% means rank 1-3 and rank 9-21 from sorted ROIs. min, avg, and
max indicate the minimum, average, and maximum value in selected part from ROIs.
No. feat. description No. feat. description No. feat. description
0 avg. # mts 7 std. # cells 14 std. # mts in top 10%
1 max. # mts 8 ratio of avg. mts/cells 15 std. # cells in top 10%
2 std. # mts 9 ratio of max. mts/cells 16 min. # mts in top 10%
3 B&R of avg. # mts 10 avg. # mts in top 10% 17 min. # cells in top 10%
4 B&R of max. # mts 11 min. # mts 18 avg. # mts in 30-70%
5 avg. # cells 12 min. # cells 19 max. # mts in 30-70%
6 max. # cells 13 ratio of min. mts/cells 20 std. # mts in 30-70%
2.3 Tumor Proliferation Score Prediction
In the final module, we encode each slide into a feature vector and train an
SVM to predict the tumor proliferation scores. The feature vector consists of
the number of mitoses and cells in each patch through the steps previously de-
scribed, in addition to 21 features based on statistical information, as shown
in TABLE 1. Since we have no prior knowledge of which features are relevant
for tumor proliferation score prediction, we find the best feature vector through
cross validation from various feature combinations. We performed 10-fold cross
validation using 500 training pairs with various C values of support vector ma-
chines (SVMs) with radial basis function (RBF) kernel in which the gamma of
RBF kernel is fixed to 1/the dimension of feature. Finally, we selected combina-
tions of features with the best performance. To reduce the search permutations,
we reduced the dimension of the feature vector to 14 features.
3 Results
In this section, we introduce the dataset used for training and validation and
show the performance of each individual component in the proposed system. In
addition, all experimental results except for validation were evaluated in a public
challenge.
3.1 Datasets
We used two datasets1 for developing the fully automated tumor proliferation
score prediction system. First, the auxiliary dataset containing annotated mitosis
regions from two pathologists are used to build a mitosis detector. The training
dataset includes 656 patches of 1 HPF or 10 HPFs from 73 patients from three
pathology centers, and 34 patches of 10 HPFs from 34 patients are used for
testing. The training dataset is randomly split to validate the mitosis detector,
1 http://tupac.tue-image.nl/node/3
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Table 2. F1 scores in mitosis detection. * indicates that additional data was used for
training. Proposed method is based on L-view architecture with 128x128 input size.
Method Validation Test
Proposed 0.731 0.652
Team A∗ - 0.648
Team B - 0.616
Team C∗ - 0.601
and the validation dataset includes 142 mitoses from 6 patients. Secondly, to
train the entire system, we used the main dataset which consists of 500 training
WSIs and 321 testing WSIs. Each WSI has two corresponding scores, a mitosis
counting based score indicating one of three classes and a molecular data based
score [10] which is a continuous value. To validate the entire system, we used
10-fold cross validation.
3.2 Experiments
We evaluated on three tasks to validate the performance of the proposed system.
Our results were compared with the other approaches in the challenge. 2 First,
the mitosis detection performance is measured via F1-score. The performance of
the entire system is based on two evaluation metrics: quadratic weighted Cohen’s
kappa for the mitosis counting based score and Spearman’s correlation coefficient
for the molecular based score.
Mitosis detection: We fixed the batch size to 128 and initial learning rate to
0.1, and applied the same two-step training procedure for all model configura-
tions during training. The k of our L-view architecture is 3 in the first training
phase, and color, brightness and contrast augmentation is used in various combi-
nations. The learning rate is 0.1 for the first 8 epochs of the first training phase,
and 0.1, 0.01 and 0.001 for 8, 12 and 14 epochs of the second training phase.
The evaluation results are shown in TABLE 2. With the L-view architecture, we
obtain 0.731 and 0.652 F1-score on the validation and test, respectively. In case
of training without false positives, the performance degradation of 0.1 F1-score
was observed in our validation set.
Mitosis counting based proliferation score prediction: After selecting the
mitosis detector with the best performance, we trained the tumor proliferation
score prediction module. We evaluated quadratic weighted Cohen’s kappa score
using 10-fold cross validation and found the best feature combination. The min
related feature values were found to be unimportant, so features 11, 12, 13, 16, 17
were removed from the combination list. Finally, we found the best performance
to be shown by a 12 dimensional feature vector of the features 0, 1, 2, 3, 4, 5, 6, 7,
10, 15, 18, 20 from TABLE 1. The C value of SVMs was 0.03125. The evaluation
results are shown in TABLE 3. The kappa score was 0.504 on the validation
2 Compared methods are denoted by alphabet to anonymize the names of the partic-
ipating teams.
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Table 3. Mitosis counting based proliferation score prediction results in validation and
test. The evaluation metric is Quadratic weighted Cohen’s kappa score. * indicates that
additional data was used for training. ** is the semi-automatic method where ROIs
are selected by a pathologist.
Method Validation Test
Proposed 0.504 0.567
Team D∗∗ - 0.543
Team B - 0.534
Team E∗ - 0.462
dataset and 0.567 on the test dataset, and the proposed system outperformed
all other approaches. In addition, our system is even better than both the semi-
automatic model and the model trained by using additional data.
Molecular data based proliferation score prediction: The same method
is used to find the best feature combination for predicting the molecular data
based score. The min related features were once again found to be unimportant
and removed. The evaluation results are shown in TABLE 4. The 13 dimensional
best feature vector includes features 0, 1, 2, 3, 4, 5, 6, 7, 8, 10, 14, 18, 20 from
TABLE 1, and the C value of SVMs was 0.25. We obtained 0.642 Spearman score
on the validation dataset and 0.617 on the test dataset. Our system significantly
outperformed all other approaches. Through the best feature combination, we
discovered that the values of features 8 and 14, rather than 15, are important
in predicting the molecular data based score. In other words, the key factor for
estimating this score is not cell information but the number of mitoses. This
affirms the high correlation of mitotic count and tumor proliferation speed.
4 Conclusion
We presented a fully automated unified system for predicting tumor proliferation
scores directly from breast histopathology WSIs. The proposed system enables
fully automated modular prediction of two tumor proliferation scores based on
mitosis counting and molecular data. Our work confirms that a mitosis detection
module could be integrated in prognostic grading system that is more practical
in a clinical scenario. In addition, we demonstrated that our system achieved
state-of-the-art performance in proliferation scores prediction.
Table 4. Molecular data based proliferation score prediction results in validation and
test. Evaluation metric is Spearmans correlation coefficient.
Method Validation Test
Proposed 0.642 0.617
Team F - 0.516
Team B - 0.503
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